Sept 22 (Reuters) – Filana Therapeutics, Inc.: * FILANA THERAPEUTICS ANNOUNCES FDA LIFT OF CLINICAL HOLD ON SIMUFILAM, ENABLING PHASE 2A STUDY IN TSC-RELATED EPILEPSY * FILANA THERAPEUTICS, – FDA
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 22 (Reuters) - Palo Alto Networks said on Tuesday it would launch a new…
Sept 22 (Reuters) - Palo Alto Networks said on Tuesday it would launch a new…
Sept 22 (Reuters) - Palo Alto Networks said on Tuesday it would launch a new…
VIDEO SHOWS: ARCHIVE VISION AND STILL PHOTOGRAPHS OF ARSENAL MANAGER MIKEL ARTETA RESENDING WITH SHOTLIST…
Mumbai (Maharashtra) [India], September 21: Whistling Woods International’s (WWI) School of Creative Arts successfully concluded…
LIBYA'S NOC SAYS IT EXPECTS LOSSES TO RISE IF SHUTDOWN PERSISTS (The article has been…